Develops immunotherapies for autoimmune disorders and cancer.
Jun 2026Revenue $6.72M/yrExpenses $14.4M/yr
No trendCash runway ≈ 1 month from Jun 2026
Figures by year
When will HCW Biologics be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $6.72M and expenses $14.4M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $54.2K | $13.2M | −$13.2M |
| Dec 2024 | $2.57M | $32.0M | −$29.5M |
| Dec 2023 | $2.84M | $28.6M | −$25.7M |
| Dec 2022 | $6.72M | $21.8M | −$15.1M |
| Dec 2021 | $0.00 | $13.4M | −$13.4M |
| Dec 2020 | $4.10M | $9.92M | −$5.82M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.